REG - EnSilica PLC - Cross-Trading on the U.S. OTCQX Market

EnSilicaAnnouncement

Today 07:00

For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20260415:nRSO4802Aa&default-theme=true

RNS Number : 4802A  EnSilica PLC  15 April 2026

15 April 2026

NEWS RELEASE

("EnSilica", the "Company" or the "Group")

 

EnSilica to Start Cross-Trading on the U.S. OTCQX Market

 

EnSilica plc (AIM: ENSI), a leading fabless, application-specific chipmaker,
is pleased to announce that its ordinary shares of 0.1 pence each ("Ordinary
Shares") have been approved to trade on the OTCQX Best Market ("OTCQX Market")
in the United States. The Ordinary Shares will commence cross-trading on the
OTCQX Market in the United State later today under the ticker symbol
"ENSIF".

 

The OTCQX Market, recognised by the United States Securities and Exchange
Commission as an established public market, serves as a leading platform for
both domestic and international growth-stage companies. Admission to the OTCQX
Market requires issuers to maintain up-to-date financial reporting, meet
minimum bid price criteria, and complete an annual verification and management
certification process.

 

Ian Lankshear, CEO of EnSilica, said:

"Investors globally are rightly very focused on the SpaceTech sector given its
clear commercial importance, and as a successful British company, with a
strong position in satellite chip supply, we believe it is the right moment to
increase EnSilica's exposure to U.S. investors and facilitate their ability to
trade in our stock by joining the OTCQX Market."

 

The Ordinary Shares will continue to trade on AIM under the ticker "ENSI".

 

 EnSilica plc                                                           via Novella Communications

 Ian Lankshear, Chief Executive Officer                                 +44 (0)20 3151 7008

 Kristoff Rademan, Chief Financial Officer

 www.ensilica.com (http://www.ensilica.com)

 Allenby Capital Limited (Nominated Adviser & Joint Broker)

 Jeremy Porter / Vivek Bhardwaj (Corporate Finance)                     +44 (0)20 3328 5656

 Joscelin Pinnington / Tony Quirke (Sales & Corporate Broking)          info@allenbycapital.com (mailto:info@allenbycapital.com)

 Panmure Liberum Limited (Joint Broker)

 Edward Mansfield / Will King / Phoebe Bunce                            +44 (0)20 3100 2000

 Novella Communications (Investor & Financial Public Relations)         +44 (0)20 3151 7008

 Tim Robertson / Aeliya Bilgrami                                        ensilica@novella-comms.com (mailto:ensilica@novella-comms.com)

 

About EnSilica plc

EnSilica is a fabless, application-specific chipmaker, combining deep domain
and system-level expertise with world-class capability in RF, mmWave,
mixed-signal and complex digital IC design. The Company serves customers
across the space and communications, industrial, automotive and healthcare
markets, where safety and security and reliability are critical.

A growing portfolio of reusable IP and silicon platforms underpins a
repeatable, scalable delivery model, reducing development risk, cost and time
to market while supporting long-term supply revenues. EnSilica has a strong
track record of delivering production-proven silicon to demanding industry
standards. Headquartered near Oxford, UK, the Company operates design centres
across the UK, India, Brazil and Hungary.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  MSCIIMLTMTIBBAF



            Copyright 2019 Regulatory News Service, all rights reserved